StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Reported (IFRS) basic EPS by Year

Reported (IFRS) basic EPS ($ per share) ($)

QuarterlyAnnual

AstraZeneca Reported (IFRS) basic EPS: $6.60 in FY2025, up 45.4% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
6.60
Period ended Dec 31, 2025
Change on a year earlier
+45.4%
4.54 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| EPS | $6.60 | $0.11 | $2.26 | $0.19 | $9.16 | 12 | 11”

Source: Form 6-K FY2025Q4 Earnings Release ↗

Reported in Form 6-K / 20-F Consolidated Income Statement.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported (IFRS) basic EPS ($ per share) ($)Year on yearSource
FY2025Dec 31, 20256.60+45.4%Form 6-K FY2025Q4 Earnings Release ↗
FY2024Dec 31, 20244.54+18.2%Form 6-K FY2024Q4 Earnings Release ↗
FY2023Dec 31, 20233.84+81.1%Form 6-K FY2023Q4 Earnings Release ↗
FY2022Dec 31, 20222.12+2,550.0%Form 6-K FY2022Q4 Earnings Release ↗
FY2021Dec 31, 20210.08-96.7%Form 6-K FY2021Q4 Earnings Release ↗
FY2020Dec 31, 20202.44+136.9%Form 6-K FY2020Q4 Earnings Release ↗
FY2019Dec 31, 20191.03-39.4%Form 20-F (filed 2020-03-03) ↗
FY2018Dec 31, 20181.70-28.3%Form 20-F (filed 2019-03-05) ↗
FY2017Dec 31, 20172.37-14.4%Form 20-F (filed 2018-03-06) ↗
FY2016Dec 31, 20162.77+24.2%Form 20-F (filed 2018-03-06) ↗
FY2015Dec 31, 20152.23–Form 20-F (filed 2018-03-06) ↗

Cite this data

StockData. (2026). AstraZeneca Reported (IFRS) basic EPS ($), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep-eps-cmp

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.